Goenka Mahesh, Afzalpurkar Shivaraj, Goenka Usha, Das Sudipta Sekhar, Mukherjee Mohuya, Jajodia Surabhi, Shah Bhavik Bharat, Patil Vikram Uttam, Rodge Gajanan, Khan Ujjwayini, Bandyopadhyay Syamasis
Director and Head, Medicine, Apollo Gleneagles Hospitals, Kolkata, West Bengal.
Registrar, Institute of Gastrosciences and Liver, Apollo Gleneagles Hospitals, Kolkata, West Bengal.
J Assoc Physicians India. 2020 Nov;68(11):14-19.
Seroprevalence studies for COVID-19 evaluate the extent of undetected transmission in a defined community, with special significance among health care workers (HCW) owing to their greater exposure and potential to transmit.
A total of 1122 HCW (approximately 25% of the employees) of a large tertiary care hospital in India were recruited for this cross-sectional study. COVID PCR-positive HCW were excluded. Based on their risk-assessment, participants were grouped into three categories. A questionnaire was administered and they were tested for SARS-CoV-2-IgG antibodies using the chemiluminescence.
The overall seroprevalence among workers was 11.94%, which included 19.85% in COVID units, 11.09% in non-COVID units, and 8% in administrative workers (p=0.007). Antibody prevalence was highest in the department of gastroenterology (11.94%), followed by oncology (10.53%), pathology (10.26%), emergency medicine (7.84%) and critical care medicine (7%). Housekeeping staff, food and beverage staff, lab assistants and technicians had higher seroprevalence rate than doctors and nurses (p < 0.0001). HCW with a history of BCG vaccination in childhood and those who received an adequate prophylactic dose of hydroxychloroquine (HCQ) had a lower seroprevalence as compared to those who did not (7.31% vs. 16.8% and 1.30% vs. 11.25% respectively).
BCG vaccination, HCQ prophylaxis, and the job profile influence the seroprevalence rate in HCW. Seroprevalence rate and follow-up evaluation of its durability may help hospitals to triage their staff at risk, rationalize their placement, prioritize the use of PPE, thereby potentially reducing the risk.
新型冠状病毒肺炎(COVID-19)血清流行率研究旨在评估特定社区中未被发现的传播程度,由于医护人员(HCW)接触风险更高且具有传播潜力,因此在他们当中进行此类研究具有特殊意义。
本横断面研究招募了印度一家大型三级护理医院的1122名医护人员(约占员工总数的25%)。排除新冠病毒核酸检测呈阳性的医护人员。根据风险评估,将参与者分为三类。发放问卷,并使用化学发光法检测他们的新冠病毒IgG抗体。
工作人员的总体血清流行率为11.94%,其中新冠病房为19.85%,非新冠病房为11.09%,行政人员为8%(p=0.007)。抗体流行率在胃肠病科最高(11.94%),其次是肿瘤科(10.53%)、病理科(10.26%)、急诊科(7.84%)和重症医学科(7%)。家政人员、餐饮服务人员、实验室助理和技术人员的血清流行率高于医生和护士(p<0.0001)。儿童时期接种过卡介苗(BCG)的医护人员以及接受过足量预防性羟氯喹(HCQ)治疗的医护人员的血清流行率低于未接种或未接受治疗的人员(分别为7.31%对16.8%和1.30%对11.25%)。
卡介苗接种、羟氯喹预防措施以及工作岗位会影响医护人员的血清流行率。血清流行率及其持久性的随访评估可能有助于医院对有风险的工作人员进行分类,合理安排他们的工作岗位,优先使用个人防护装备,从而潜在地降低风险。